E1 |
73 kDa |
649 |
− DNA helicase
− initiation of viral DNA replication
− forms a replication complex with E2
− binds to the p62 protein subunit of the human homolog of transcription factor TFHII and the p80 protein
− interaction with DNA polymerase alpha
|
[31,32,33] |
E2 |
42 kDa |
365 |
− initiation of viral DNA replication
− transcription factor
− interaction with the E1 protein, bromodomain-containing protein 4 (Brd4), DNA topoisomerase II-binding protein 1 (TopBP1)
− control of early region viral gene expression
|
[34,35] |
E4 |
10.5 kDa |
92 |
− involves cell cycle arrest
− disruption of keratin filaments
− expressed as an E1^E4 transcript
|
[36,37,38] |
E5 |
9.4 kDa |
83 |
− transmembrane protein
− localized in the Golgi apparatus
− regulates growth signaling pathways via activation of the epidermal growth factor receptor (EGFR), downstream regulation of the Ras–Raf–MAP kinase pathway or the PI3K–Akt pathway
− proliferation of the altered cell
− inhibition of apoptosis due to the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and the Fas ligand (FasL)
− prevents formation of the death-inducing signaling complex (DISC) induced by TRAIL
− interaction with MHC/HLA class I
− stimulation of interferon β1 (IFNβ1) and interferon regulatory factor 1 (IRF-1)
− interaction with other oncoproteins
− interaction with vacuolar ATPase, platelet-derived growth factor (PDGF), zinc transporter ZnT1, protocadherin 1 (PCDH1)
|
[39,40,41,42,43,44,45] |
E6 |
18–19.2 kDa |
150 |
− oncoprotein
− p53 protein degradation
− upregulation of the expression of hTERT telomerase
− interaction with caspase 8
− cell cycle deregulation
− collaborative action with the E7 protein leads to malignant transformation
− interaction with the Bak protein
− interaction with the Bax protein
− interaction with E6AP ubiquitin ligase that is essential for E6 stability
− interaction with HECT domain-containing ubiquitin ligase EDD
− interaction with proteins containing PDZ domains
|
[19,46,47,48,49,50,51,52,53,54] |
E7 |
11 kDa |
98 |
− oncoprotein
− pRB inactivation
− interaction with centromere protein C (CENP-C)
− functional inactivation permitting cell progression to the S-phase of cell cycle
− uncontrolled cell division
− collaborative action with the E6 protein leads to malignant transformation
− interaction with cellular non-receptor protein tyrosine phosphatase PTPN14
− interaction with the pRB-related members of the pocket protein family like p107 and p130 involved in cell cycle regulation
− association with the 600 kDa retinoblastoma protein-associated factor (p600)
− association with members of the cullin 2 (Cul2) ubiquitin ligase complex
|
[55,56,57,58,59,60,61] |
L1 |
55 kDa |
531 |
− major capsid protein of a virus-like particle (VLP)
− binding of the basal membrane of keratinocytes substantively to heparin sulfate proteoglycans (HSPG)
− attends in the mechanism of viral entry by binding to the α6 integrin
|
[62,63] |
L2 |
74 kDa |
462 |
− minor protein of the capsid
− promotes the transportation of the virion into the nucleus of the host cell by interacting with host dynein following endosomal entry
− interaction with the Kapα2β1, Kapβ2, and Kapβ3 receptors
− mediates the egress of the viral genome from endosomes
|
[9,30,64,65] |